SAMANTHA LEWIS: Open Payments
NPI 1619222494 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 52 payments from 17 companies in 2025. Trend: 2023 $1,466 · 2024 $1,547 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 14 | $229 |
| Novo Nordisk Inc | 10 | $188 |
| PFIZER INC. | 4 | $65 |
| Abbott Laboratories | 3 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| Amgen Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $32 |
Products named: Veozah, Wegovy, FREESTYLE LIBRE 3, NEFFY, LAGEVRIO, GEMTESA, Ozempic, OTEZLA.
Industry payments across GA — which companies pay providers there.
